voglibose: Clinical Trials

7 trials of voglibose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 unknown. 7 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Completed 6, Unknown 1
Phase 22Completed 2

Follow voglibose: new trials by email Literature Review of voglibose trials Research Report on voglibose

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients
Voglibose + Metformin, Glibenclamide + Metformin - Diabetes Mellitus Type 2 Without Complication
Phase 3UnknownUniversity of Zambia1182023-08-012023-07-03
A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients
ipragliflozin, alpha glucosidase inhibitor - Type 2 Diabetes Mellitus
Phase 3CompletedAstellas Pharma Inc1132010-10-212025-05-30
MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)
Comparator: Placebo, Sitagliptin, Voglibose - Diabetes Mellitus, Non-Insulin-Dependent
Phase 3CompletedMerck Sharp & Dohme LLC1332009-02-052017-05-15
Japanese P III vs Voglibose and Placebo
BI 1356, voglibose placebo, BI 1356 placebo - Diabetes Mellitus, Type 2
Phase 3CompletedBoehringer Ingelheim5612008-04-012014-01-27
Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
Alogliptin and voglibose - Type 2 Diabetes Mellitus
Phase 2 / Phase 3CompletedTakeda1792007-06-012012-02-03
Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in Japan
Alogliptin and voglibose, Voglibose - Type 2 Diabetes Mellitus
Phase 2 / Phase 3CompletedTakeda2302007-01-012012-02-03
A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)
sitagliptin phosphate, Comparator: voglibose - Diabetes Mellitus, Non-Insulin-Dependent
Phase 3CompletedMerck Sharp & Dohme LLC3192007-01-012016-02-05

Conditions studied

Diabetes Mellitus, Type 2 (6)  ·  Diabetes Mellitus (3)

Sponsors

Merck Sharp & Dohme LLC (2)  ·  Takeda (2)  ·  Astellas Pharma Inc (1)  ·  Boehringer Ingelheim (1)  ·  University of Zambia (1)

Countries

Japan (2)

Results publications

PMID 22106975, PMID 19732457, PMID 20590736, PMID 22234149, PMID 24843714